摘要
目的:探讨纳米孔测序技术在2019冠状病毒病(COVID-19)重型患者继发感染诊疗中的应用价值。方法:共入组了来自3例COVID-19重型患者的77份临床标本,所有标本均经过热灭活后进行基于磁珠富集的总核酸抽提,构建DNA文库,通过纳米孔测序技术进行病原体检测。测序数据采用Centrifuge软件进行病原体数据库比对和R语言差异分析,以获得病原微生物的鉴定结果。比较纳米孔测序结果与呼吸道病原体筛查多重定量聚合酶链反应(PCR)检测及同一时期临床微生物检验结果,以验证纳米孔测序技术的有效性。结果:纳米孔测序结果显示,44份标本检出病原体(阳性率为57.1%),包括肺炎克雷伯菌、表皮葡萄球菌、屎肠球菌和狡诈菌等。其中,肺炎克雷伯菌、表皮葡萄球菌和屎肠球菌均在基于微生物培养的临床微生物检验中检出;肺炎克雷伯菌同时在呼吸道病原体筛查多重定量PCR检测中检出;狡诈菌仅在纳米孔测序中检出,综合考虑患者的临床症状进行抗菌药物治疗,患者的感染情况得到控制。结论:纳米孔测序可快速鉴定临床标本中的潜在病原体,辅助COVID-19重型患者的临床诊断和治疗方案的制订。
Objective: To explore the application value of nanopore sequencing technique in the diagnosis and treatment of secondary infections in patients with severe coronavirus disease 2019(COVID-19).Methods: A total of 77 clinical specimens from 3 patients with severe COVID-19 were collected. After heat inactivation, all samples were subjected to total nucleic acid extraction based on magnetic bead enrichment. The extracted DNA was used for DNA library construction, then nanopore real-time sequencing detection was performed. The sequencing data were subjected to Centrifuge software database species matching and R program differential analysis to obtain potential pathogen identification. Nanopore sequencing results were compared with respiratory pathogen qPCR panel screening and conventional microbiological testing results to verify the effectiveness of nanopore sequencing detection.Results: Nanopore sequencing results showed that positive pathogen were obtained in 44 specimens(57.1%). The potential pathogens identified by nanopore sequencing includedKlebsiella pneumoniae,Staphylococcus epidermidis,Enterococcus faeciumandDolosigranulum pigrum, et al.Klebsiella pneumoniae,Staphylococcus epidermidis,Enterococcus faeciumwere also detected in clinical microbiological culture-based detection;Klebsiella pneumoniaewas detected in respiratory pathogen screening qPCR panel;Dolosigranulum pigrumwas only detected by the nanopore sequencing technique. Comprehensive considerations with the clinical symptoms, the patient was treated with antibiotics againstDolosigranulum pigrum, and the infection was controlled.Conclusion: Nanopore sequencing may assist the diagnosis and treatment of severe COVID-19 patients through rapid identification of potential pathogens.
作者
贾小芳
张小楠
凌云
张欣宇
田棣
廖怡馨
易志刚
卢洪洲
JIA Xiaofang;ZHANG Xiaonan;LING Yun;ZHANG Xinyu;TIAN Di;LIAO Yixin;YI Zhigang;LU Hongzhou(Scientific Research Department,Shanghai Public Health Clinical Center,Shanghai 201508,China;Infectious Disease Department,Shanghai Public Health Clinical Center,Shanghai 201508,China;Department of Infection and Immunology,Shanghai Public Health Clinical Center,Shanghai 201508,China)
出处
《浙江大学学报(医学版)》
CAS
CSCD
北大核心
2021年第6期748-754,共7页
Journal of Zhejiang University(Medical Sciences)
基金
上海市科学技术委员会第二批应急科技攻关专项(20411950200)
上海市2020年度“科技创新行动计划”医学创新研究专项(20Z11900900)
国家自然科学基金(81801991)
中国肝炎防治基金会天晴肝病研究基金(TQGB20200164)。
关键词
2019冠状病毒病
严重急性呼吸综合征冠状病毒2
纳米孔测序
宏基因组测序
病原体检测
Coronavirus disease 2019
Severe acute respiratory syndrome coronavirus 2
Nanopore sequencing
Metagenomics next-generation sequencing
Pathogen detection